(VIANEWS) – Nucor Corporation (NUE), Bank of Marin Bancorp (BMRC), iRadimed Corporation (IRMD) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Nucor Corporation (NUE)

71.8% sales growth and 27.49% return on equity

Nucor Corporation produces and sells steel, and other steel products.

Nucor Corporation’s sales growth this year is anticipated to be 71.6% and a negative 11.5% for next year.

Year-on-year quarterly revenue growth grew by 103.1%, now sitting on 25.99B for the twelve trailing months.

Volume

Today’s last reported volume for Nucor Corporation is 1726490 which is 48.01% below its average volume of 3321110.

Nucor Corporation’s sales growth for the next quarter is 71.8%. The company’s growth estimates for the present quarter and the next is 884.6% and 345.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.49%.

Volatility

Nucor Corporation’s last day, last week, and last month’s current intraday variation average was 5.01%, 4.63%, and 4.21%, respectively.

Nucor Corporation’s highest amplitude of average volatility was 4.52% (day), 4.50% (last week), and 5.87% (last month), respectively.

Nucor Corporation’s Stock Yearly Top and Bottom Value

Nucor Corporation’s stock is valued at $130.66 at 16:22 EST, higher than its 52-week high of $128.81.

Nucor Corporation’s Moving Average

Nucor Corporation’s value is way higher than its 50-day moving average of $108.32 and way above its 200-day moving average of $99.45.

2. Bank of Marin Bancorp (BMRC)

21.9% sales growth and 7.75% return on equity

Bank of Marin Bancorp is the holding company of Bank of Marin. It provides financial services to individuals and professionals in San Francisco Bay Area.

Bank of Marin Bancorp’s sales growth this year is expected to be 8.9% and 12.1% for next year.

Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 111.87M for the twelve trailing months.

Volume

Today’s last reported volume for Bank of Marin Bancorp is 63786 which is 46.65% above its average volume of 43493.

Bank of Marin Bancorp’s sales growth for the next quarter is 21.9%. The company’s growth estimates for the present quarter and the next is a negative 3.3% and negative -15.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.75%.

Volatility

Bank of Marin Bancorp’s last day, last week, and last month’s current intraday variation average was 1.86%, 1.97%, and 1.44%, respectively.

Bank of Marin Bancorp’s highest amplitude of average volatility was 2.79% (day), 3.33% (last week), and 2.89% (last month), respectively.

Bank of Marin Bancorp’s Stock Yearly Top and Bottom Value

Bank of Marin Bancorp’s stock is valued at $33.43 at 16:22 EST, way under its 52-week high of $39.65 and way above its 52-week low of $30.05.

Bank of Marin Bancorp’s Moving Average

Bank of Marin Bancorp’s worth is below its 50-day moving average of $33.98 and below its 200-day moving average of $36.08.

3. iRadimed Corporation (IRMD)

20% sales growth and 16.6% return on equity

IRADIMED CORPORATION designs, produces, markets and distributes compatible magnetic resonance imaging (MRI), medical devices and accessories in the United States as well as internationally.

iRadimed Corporation’s sales growth this year is expected to be 31.1% and 9.7% for next year.

Year-on-year quarterly revenue growth grew by 33.5%, now sitting on 44.9M for the twelve trailing months.

Volume

Today’s last reported volume for iRadimed Corporation is 66978 which is 26.67% below its average volume of 91338.

iRadimed Corporation’s sales growth for the next quarter is 20%. The company’s growth estimates for the present quarter and the next is 200% and 115.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.6%.

Volatility

iRadimed Corporation’s last day, last week, and last month’s current intraday variation average was 4.55%, 2.92%, and 4.34%, respectively.

iRadimed Corporation’s highest amplitude of average volatility was 6.70% (day), 7.70% (last week), and 6.57% (last month), respectively.

iRadimed Corporation’s Stock Yearly Top and Bottom Value

iRadimed Corporation’s stock is valued at $31.22 at 16:22 EST, way below its 52-week high of $55.92 and way higher than its 52-week low of $27.08.

iRadimed Corporation’s Moving Average

iRadimed Corporation’s worth is way under its 50-day moving average of $44.72 and way under its 200-day moving average of $40.77.

4. Celanese (CE)

17.8% sales growth and 45.49% return on equity

Celanese Corporation is a specialty material and technology company that manufactures and markets high-performance engineered polymers both in the United States as well internationally.

Celanese’s sales growth this year is anticipated to be 50.2% and a negative 0.8% for next year.

Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.54B for the twelve trailing months.

Volume

Today’s last reported volume for Celanese is 775452 which is 27.9% below its average volume of 1075620.

Celanese’s sales growth for the next quarter is 17.8%. The company’s growth estimates for the present quarter and the next is 140.7% and 18.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.49%.

Volatility

Celanese’s last day, last week, and last month’s current intraday variation average was 0.41%, 2.07%, and 2.26%, respectively.

Celanese’s highest amplitude of average volatility was 2.54% (day), 3.44% (last week), and 3.53% (last month), respectively.

Celanese’s Stock Yearly Top and Bottom Value

Celanese’s stock is valued at $141.83 at 16:22 EST, way under its 52-week high of $176.50 and higher than its 52-week low of $132.26.

Celanese’s Moving Average

Celanese’s worth is under its 50-day moving average of $143.22 and below its 200-day moving average of $155.49.

5. Camden Property Trust (CPT)

17.3% sales growth and 8.03% return on equity

Camden Property Trust is an S&P 400 Company. It’s primarily involved in the management, ownership, development, renovation, acquisition and construction multifamily apartments communities.

Camden Property Trust’s sales growth this year is anticipated to be 14.9% and 8% for next year.

Year-on-year quarterly revenue growth grew by 16.5%, now sitting on 1.17B for the twelve trailing months.

Volume

Today’s last reported volume for Camden Property Trust is 1359300 which is 1.19% above its average volume of 1343310.

Camden Property Trust’s sales growth for the next quarter is 17.3%. The company’s growth estimates for the ongoing quarter and the next is 43.3% and 79.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.03%.

Volatility

Camden Property Trust’s last day, last week, and last month’s current intraday variation average was 3.35%, 1.38%, and 1.49%, respectively.

Camden Property Trust’s highest amplitude of average volatility was 4.85% (day), 2.83% (last week), and 2.46% (last month), respectively.

Camden Property Trust’s Stock Yearly Top and Bottom Value

Camden Property Trust’s stock is valued at $156.89 at 16:22 EST, way under its 52-week high of $180.37 and way higher than its 52-week low of $117.07.

Camden Property Trust’s Moving Average

Camden Property Trust’s value is below its 50-day moving average of $166.27 and below its 200-day moving average of $160.52.

6. EVO Payments (EVOP)

8.6% sales growth and 4.98% return on equity

EVO Payments, Inc. is an integrated merchant acquirer/payment processor in Europe and the Americas.

EVO Payments’s sales growth this year is anticipated to be 11.7% and 12.5% for next year.

Year-on-year quarterly revenue growth grew by 14.2%, now sitting on 496.64M for the twelve trailing months.

Volume

Today’s last reported volume for EVO Payments is 178222 which is 16.12% below its average volume of 212493.

EVO Payments’s sales growth for the next quarter is 8.6%. The company’s growth estimates for the ongoing quarter and the next is 30.8% and 23.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.98%.

Volatility

EVO Payments’s last day, last week, and last month’s current intraday variation average was 3.36%, 2.04%, and 1.62%, respectively.

EVO Payments’s highest amplitude of average volatility was 3.40% (day), 3.33% (last week), and 2.88% (last month), respectively.

EVO Payments’s Stock Yearly Top and Bottom Value

EVO Payments’s stock is valued at $22.90 at 16:22 EST, way under its 52-week high of $30.46 and way higher than its 52-week low of $20.07.

EVO Payments’s Moving Average

EVO Payments’s worth is below its 50-day moving average of $23.35 and under its 200-day moving average of $24.20.

LEAVE A REPLY

Please enter your comment!
Please enter your name here